VTR:NYE-Ventas Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 65.83

Change

-0.79 (-1.19)%

Market Cap

USD 21.02B

Volume

3.20M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ventas Inc is a real estate investment trust. The Company has diversified portfolio of seniors housing and healthcare properties located throughout the United States, Canada and the United Kingdom.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-06 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 92.95B
DOC Healthpeak Properties Inc

N/A

USD 13.10B
CTRE CareTrust REIT Inc.

N/A

USD 5.46B
AHR American Healthcare REIT, Inc.

N/A

USD 5.17B
NHI National Health Investors Inc

N/A

USD 3.54B
LTC LTC Properties Inc

N/A

USD 1.55B
UHT Universal Health Realty Income..

N/A

USD 0.53B
CHCT Community Healthcare Trust Inc

N/A

USD 0.45B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.40B
GMRE Global Medical REIT Inc

N/A

N/A

ETFs Containing VTR

BYRE Principal Exchange-Traded.. 9.62 % 0.00 %

N/A

USD 0.01B
SRHR Elevation Series Trust 7.46 % 0.00 %

N/A

USD 0.05B
WNEW:LSE WisdomTree New Economy Re.. 5.92 % 0.00 %

N/A

N/A
WTRE:LSE WisdomTree New Economy Re.. 5.92 % 0.00 %

N/A

N/A
WTRE:XETRA WisdomTree New Economy Re.. 5.67 % 0.00 %

N/A

USD 2.55M
WTER:XETRA WisdomTree New Economy Re.. 5.67 % 0.00 %

N/A

USD 5.01M
JPRE JPMorgan Realty Income ET.. 5.29 % 0.00 %

N/A

USD 0.39B
JRE Janus Henderson U.S. Real.. 5.07 % 0.00 %

N/A

USD 0.02B
DJRE:AU SPDR Dow Jones Global Rea.. 3.13 % 0.00 %

N/A

USD 0.43B
TRET:SW VanEck Global Real Estate.. 2.53 % 0.00 %

N/A

USD 0.30B
GBRE:SW SPDR® Dow Jones Global R.. 2.14 % 0.00 %

N/A

USD 0.26B
GLRA:SW SPDR® Dow Jones Global R.. 2.14 % 0.00 %

N/A

USD 0.05B
GLRA:LSE SPDR Dow Jones Global Rea.. 2.10 % 0.00 %

N/A

USD 0.05B
RENT:AU 2.03 % 0.00 %

N/A

N/A
REAI Tidal ETF Trust - Intelli.. 1.92 % 0.00 %

N/A

USD 3.28M
DRW 0.00 % 0.58 %

N/A

N/A
EWRE 0.00 % 0.40 %

N/A

N/A
FRI First Trust S&P REIT Inde.. 0.00 % 0.50 %

N/A

USD 0.14B
REZ iShares Residential and M.. 0.00 % 0.48 %

N/A

USD 0.78B
OLD 0.00 % 0.50 %

N/A

N/A
HOMZ The Hoya Capital Housing .. 0.00 % 0.00 %

N/A

USD 0.03B
WREI 0.00 % 0.32 %

N/A

N/A
TRET:F VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.28B
SPYJ:XETRA SPDR® Dow Jones Global R.. 0.00 % 0.00 %

N/A

N/A
SPY2:XETRA SPDR® Dow Jones Global R.. 0.00 % 0.00 %

N/A

N/A
TREG:LSE VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.30B
TRET:LSE VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.30B
REIT ALPS Active REIT ETF 0.00 % 0.00 %

N/A

USD 0.04B
SPY2:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.78% 80% B- 90% A-
Dividend Return 0.82% 14% F 37% F
Total Return 12.60% 81% B- 90% A-
Trailing 12 Months  
Capital Gain 39.68% 87% B+ 94% A
Dividend Return 3.88% 20% F 64% D
Total Return 43.56% 87% B+ 95% A
Trailing 5 Years  
Capital Gain 143.09% 92% A 84% B
Dividend Return 33.35% 38% F 75% C
Total Return 176.44% 92% A 84% B
Average Annual (5 Year Horizon)  
Capital Gain 10.48% 80% B- 70% C-
Dividend Return 14.11% 73% C 74% C
Total Return 3.63% 27% F 70% C-
Risk Return Profile  
Volatility (Standard Deviation) 26.63% 40% F 36% F
Risk Adjusted Return 53.00% 67% D+ 68% D+
Market Capitalization 21.02B 91% A- 93% A

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.00 10% 2%
Price/Book Ratio 2.76 30% 30%
Price / Cash Flow Ratio 22.36 27% 13%
Price/Free Cash Flow Ratio 21.98 30% 12%
Management Effectiveness  
Return on Equity 0.84% 27% 30%
Return on Invested Capital 3.04% 36% 36%
Return on Assets 1.80% 45% 43%
Debt to Equity Ratio 125.48% 10% 27%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector